On June 16, distributer Q Medical invited practitioners to The Cinnamon Club in London for the UK launch of vaginal rejuvenation device EVA.
Guests received cocktails on arrival and were treated to a dinner while they networked with other medical professionals, doctors and women’s health specialists.
Research coordinator, Dr David Bosoni, provided a presentation on the energy-based device, which was followed by a question and answer session.
He explained that the system of EVA employs a proprietary version of radiofrequency that aims to address vaginal atrophy and laxity, external vulvar rejuvenation, genitourinary syndrome of menopause (GSM) and mild stress urinary incontinence (SUI).
Dr Bosoni said that one of the positive aspects of EVA is the extensive research and multiple scientific studies the product has undergone.
Charlie Pillans, managing director of Q Medical Technologies said after the event, “I hope that practitioners will consider taking on these type of technologies, look at the scientific data, make certain that the product they are using is effective and use their own clinical judgement with the individual patient concern to choose the right cause of action.”